| Primary |
| Coagulopathy |
15.2% |
| International Normalised Ratio Increased |
15.2% |
| Preoperative Care |
9.1% |
| Prophylaxis |
9.1% |
| Haemorrhage Prophylaxis |
6.1% |
| Haemorrhagic Disorder |
6.1% |
| Overdose |
6.1% |
| Anticoagulant Therapy |
3.0% |
| Atrial Fibrillation |
3.0% |
| Deep Vein Thrombosis |
3.0% |
| Haemorrhage |
3.0% |
| Haemorrhagic Disease Of Newborn |
3.0% |
| Hypertriglyceridaemia |
3.0% |
| Mitral Valve Replacement |
3.0% |
| Procoagulant Therapy |
3.0% |
| Product Used For Unknown Indication |
3.0% |
| Vitamin K |
3.0% |
| Vitamin K Deficiency |
3.0% |
|
| Skin Discolouration |
9.7% |
| Haemorrhage |
6.5% |
| Infantile Apnoeic Attack |
6.5% |
| Infusion Related Reaction |
6.5% |
| Medical Device Complication |
6.5% |
| Medication Error |
6.5% |
| Needle Issue |
6.5% |
| Oxygen Saturation Decreased |
6.5% |
| Rash Generalised |
6.5% |
| Tremor |
6.5% |
| Accidental Needle Stick |
3.2% |
| Blood Pressure Decreased |
3.2% |
| Blood Pressure Increased |
3.2% |
| Chest Pain |
3.2% |
| Clonic Convulsion |
3.2% |
| Depressed Level Of Consciousness |
3.2% |
| Device Breakage |
3.2% |
| Device Malfunction |
3.2% |
| Drug Ineffective |
3.2% |
| Dyspnoea |
3.2% |
|
| Secondary |
| Product Used For Unknown Indication |
31.5% |
| Drug Use For Unknown Indication |
14.8% |
| Chemotherapy |
9.3% |
| International Normalised Ratio Increased |
7.4% |
| Acute Myeloid Leukaemia |
3.7% |
| Extradural Haematoma |
3.7% |
| Haemorrhagic Stroke |
3.7% |
| Lung Neoplasm Malignant |
3.7% |
| Subdural Haematoma |
3.7% |
| Asthma |
1.9% |
| Diarrhoea |
1.9% |
| Embolism Venous |
1.9% |
| Hypertension |
1.9% |
| International Normalised Ratio Decreased |
1.9% |
| Pain |
1.9% |
| Pneumonia |
1.9% |
| Pyrexia |
1.9% |
| Retroperitoneal Haemorrhage |
1.9% |
| Rheumatoid Arthritis |
1.9% |
|
| Toxic Epidermal Necrolysis |
15.4% |
| Deep Vein Thrombosis |
11.5% |
| Skin Discolouration |
11.5% |
| Infantile Apnoeic Attack |
7.7% |
| Renal Failure Acute |
7.7% |
| Cerebrovascular Accident |
3.8% |
| Clonic Convulsion |
3.8% |
| Diarrhoea |
3.8% |
| Febrile Neutropenia |
3.8% |
| Medication Error |
3.8% |
| Pulse Absent |
3.8% |
| Respiratory Failure |
3.8% |
| Skin Irritation |
3.8% |
| Sputum Retention |
3.8% |
| Swollen Tongue |
3.8% |
| Tonic Clonic Movements |
3.8% |
| Vasoconstriction |
3.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
37.7% |
| Drug Use For Unknown Indication |
34.4% |
| Prophylaxis |
5.3% |
| Acute Myeloid Leukaemia |
3.1% |
| Pain |
2.4% |
| Multiple Myeloma |
2.1% |
| Hypertension |
2.0% |
| Nausea |
2.0% |
| Diarrhoea |
1.2% |
| Premedication |
1.0% |
| Pyrexia |
1.0% |
| Sepsis |
1.0% |
| Anxiety |
1.0% |
| Depression |
0.9% |
| Infection Prophylaxis |
0.9% |
| Supplementation Therapy |
0.9% |
| Vomiting |
0.9% |
| Thrombosis Prophylaxis |
0.7% |
| Chronic Lymphocytic Leukaemia |
0.7% |
| Stomatitis |
0.7% |
|
| Vomiting |
16.7% |
| Thrombocytopenia |
10.9% |
| Sepsis |
9.2% |
| Renal Failure Acute |
5.7% |
| Stevens-johnson Syndrome |
5.2% |
| Respiratory Failure |
4.6% |
| Septic Shock |
4.6% |
| Urinary Tract Infection |
4.0% |
| Weight Decreased |
4.0% |
| Wheezing |
4.0% |
| Pneumonia |
3.4% |
| Urticaria |
3.4% |
| Weight Increased |
3.4% |
| White Blood Cell Count Decreased |
3.4% |
| Hepatic Failure |
2.9% |
| Renal Failure |
2.9% |
| Thrombosis |
2.9% |
| Transplant Rejection |
2.9% |
| Unresponsive To Stimuli |
2.9% |
| White Blood Cell Count Abnormal |
2.9% |
|
